Neurocrine Biosciences Reports Second Quarter 2023 Financial Results and Raises 2023 INGREZZA Sales Guidance
Go back to Neurocrine Biosciences Reports Second Quarter 2023 Financial Results and Raises 2023 INGREZZA Sales Guidance| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 161.62 +3.33 (2.10%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $158.29 | 52 Week High | $58.46 | |||
| Open | $161.17 | 52 Week Low | $31.25 | |||
| Day High | $161.79 | P/E | N/A | |||
| Day Low | $159.32 | EPS | $-0.69 | |||
| Volume | 1,008,890 | |||||
